OP0252 Organ damage progression and long-term safety of belimumab (BEL) in patients with systemic lupus erythematosus (SLE): an extension of pivotal phase 3 bliss studies
Van Vollenhoven, R.F., Navarra, S.V., Levy, R.A., Thomas, M., Heath, A., Lustine, T., Adamkovic, A., Fettiplace, J., Wang, M.L., Ji, B., Roth, D.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials
Demopoulos, L, Polinsky, M, Steele, G, Mines, D, Blum, M, Caulfield, M, Adamkovic, A, Liu, Q, Harler, M.B, Hahn, C, Singh, A
Published in Transplantation proceedings (01.06.2008)
Published in Transplantation proceedings (01.06.2008)
Get full text
Journal Article
Pericardial effusion coincident with sirolimus therapy: a review of Wyeth's safety database
Steele, George H, Adamkovic, Anthony B, Demopoulos, Laura A, Rothrock, Linda C, Caulfield, Maureen E, Blum, Michael D, Schubert, Charles M, Hembekides, Dany D, Singh, Ajay B
Published in Transplantation (27.02.2008)
Published in Transplantation (27.02.2008)
Get more information
Journal Article